Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Pharma Companies United By a Need for Common Data Models

Posted on October 18th, 2017 by in Pharma R&D

There is nothing that pharmaceutical companies guard more fiercely than their intellectual property. Devising and patenting the next big wonder drug is every company’s dream, Continue reading “Pharma Companies United By a Need for Common Data Models” »

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 by in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »

What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?

Posted on June 14th, 2017 by in Pharmacovigilance

The health and safety of patients is of utmost concern to pharmaceutical companies, and strict regulatory requirements ensure that safety standards remain high. But pharmacovigilance becomes an ever more difficult and overwhelming practice Continue reading “What Are Best Practices in Literature Monitoring for Top-performing Pharma Companies?” »

Self-Promoting Scientists: Building Trust with the Public

Posted on May 31st, 2017 by in Pharma R&D

 

Scientist

At Sequencing the Genome: Examining Modern Medicine, an event recently held in New York City and sponsored by The Atlantic, a series of panelists spoke on many aspects of genomics ranging from its progress in treating disease to its potential for stopping epidemics Continue reading “Self-Promoting Scientists: Building Trust with the Public” »

  1. 1
  2. 2